Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Avid Radiopharmaceuticals raises $8.9mm in institutional round

Executive Summary

Molecular imaging company Avid Radiopharmaceuticals raised $8.9mm in an institutional financing round through the sale of Series A and Series B preferred stock to existing and new investors, respectively. Pfizer Strategic Investments Group led the financing, which was also backed by Lilly Ventures, RK Ventures LLC, and seed financer BioAdvance.
Deal Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies